Chromatin Accessibility Analysis: Principles, Methods, and Applications

Peripheral blood, bone marrow aspirates, and sorted hematopoietic subsets are common sample types, especially in immunology and hematology-oncology studies. Erythrocyte contamination should be removed before processing, and nucleated cells should be enriched by density-gradient centrifugation or magnetic sorting.

Sorted and Enriched Cell Populations

Flow cytometry-sorted (FACS) or magnetically enriched subpopulations yield the cleanest regulatory profiles. Sorting conditions should be optimized for speed and gentleness to preserve chromatin structure, and index sorting enables integration with downstream single-cell analysis.

Clinical and Archival Specimens

Tumor biopsies, surgical resections, and banked frozen specimens can be analyzed, provided that ischemia time and storage conditions were controlled. Quality assessment of nuclei extraction yield and integrity is performed before library construction.

Testing Items

Chromatin accessibility analysis services typically include the following deliverables:

• Genome-wide open chromatin maps (accessibility peaks) and peak annotation against promoters, enhancers, gene bodies, and intergenic regions.
• Differential accessibility analysis between experimental groups, disease states, or cell populations.
• Motif enrichment and transcription factor footprinting analysis to infer active regulatory factors.
• Nucleosome occupancy and positioning profiling derived from fragment-size distributions.
• Gene set enrichment and pathway analysis linking accessible regions to biological functions.
• Integration with transcriptomic data (e.g., RNA-seq) to associate regulatory elements with target gene expression.
• Peak-to-gene linkage and candidate enhancer identification.
• Single-cell-level cell type identification and regulatory state characterization (for scATAC-seq projects).
• Comprehensive quality control metrics, including fragment-size periodicity, transcription start site (TSS) enrichment score, fraction of reads in peaks (FRiP), and library complexity estimates.

Testing Methods

Experimental Workflow

The standard ATAC-seq workflow proceeds through the following steps: cell or nucleus isolation and counting; transposase reaction, during which Tn5 simultaneously fragments accessible DNA and tags fragments with sequencing adapters; PCR amplification using indexed primers; library purification and size selection (typically 150–600 bp); quality assessment using fluorometric quantification and capillary electrophoresis; and paired-end sequencing on a high-throughput platform. Recommended sequencing depth is 25,000–50,000 reads per cell for single-cell experiments and 50 million paired-end reads for bulk samples.

Nuclei Extraction for Tissue Samples

Tissue specimens undergo mechanical and detergent-based dissociation under cold conditions to release intact nuclei. Released nuclei are stained with DAPI or similar dyes, counted, and optionally purified by FACS before the transposition reaction. This approach minimizes mitochondrial DNA contamination and improves signal-to-noise ratios.

Bioinformatics Analysis Pipeline

Raw sequencing data undergo standard preprocessing: base calling, adapter trimming, quality filtering, and alignment to the reference genome. Duplicate reads, mitochondrial reads, and reads in blacklist regions are removed. Accessible regions are called using peak-calling algorithms, and replicate concordance is evaluated through irreproducible discovery rate (IDR) analysis. Downstream analyses include peak annotation, differential accessibility testing, motif analysis, footprinting, nucleosome occupancy inference from Tn5 insertion patterns, and integration with public datasets such as chromatin immunoprecipitation data and histone modification profiles.

Quality Control Criteria

Acceptable libraries display characteristic nucleosomal periodicity in fragment-size distributions (mononucleosome peaks at approximately 200 bp), a TSS enrichment score greater than 6–10 for bulk data (or above 8 for single-cell data), FRiP values typically above 0.2 for bulk experiments, and high library complexity. Projects are typically conducted in accredited third-party genomics laboratories under ISO/IEC 17025-aligned quality management systems, with standard operating procedures documented for reproducibility.

Applications

• Cancer biology: identifying oncogenic enhancers and super-enhancers, mapping regulatory alterations driving tumor evolution, and discovering biomarkers for patient stratification.
• Immunology: profiling regulatory landscapes of immune cell differentiation, activation, and exhaustion, including T-cell and myeloid subset characterization in infection, autoimmunity, and immunotherapy contexts.
• Developmental biology and stem cells: tracking chromatin dynamics during differentiation and reprogramming, and defining cell-type-specific regulatory codes in embryonic development.
• Drug discovery and pharmacogenomics: assessing the epigenetic impact of therapeutic compounds, deconvoluting drug mechanism of action, and supporting the development of epigenetic therapeutics.
• Complex disease genetics: interpreting non-coding disease-risk variants from genome-wide association studies by determining whether they reside in accessible regulatory elements.
• Gene regulation research: constructing gene regulatory networks by combining accessibility data with transcriptomics and transcription factor expression profiles.
• Agricultural and plant genomics: identifying regulatory variation underlying agronomic traits and stress responses in crops.

FAQ

How many cells are required for ATAC-seq?

Standard bulk ATAC-seq protocols recommend 50,000 cells, but optimized low-input protocols perform well with 500–5,000 cells, and specialized workflows can process as few as 50–100 cells. Single-cell ATAC-seq typically captures 3,000–10,000 nuclei per experiment depending on the platform.

Can frozen tissue samples be used?

Yes. Flash-frozen tissue stored at -80°C is suitable for nuclei-extraction-based ATAC-seq. Repeated freeze-thaw cycles should be avoided, as they degrade chromatin integrity and reduce library quality.

What is the difference between ATAC-seq and DNase-seq?

Both methods measure chromatin accessibility, but ATAC-seq uses Tn5 transposase and requires far less input material with shorter protocols, whereas DNase-seq relies on DNase I digestion and typically requires millions of cells. ATAC-seq has largely supplanted DNase-seq for most applications.

What sequencing depth is recommended?

For bulk ATAC-seq, 50 million paired-end reads per sample is a common target for comprehensive peak calling and footprinting. Pilot studies may use 25 million reads, while transcription factor footprinting benefits from depths of 100 million reads or more.

How long does a typical project take?

A standard bulk ATAC-seq project, from sample receipt through sequencing and bioinformatics delivery, generally requires 4–8 weeks depending on sample type, number of samples, and analysis complexity. Single-cell projects may require additional time for cell hashing or multiplexing steps.

Can chromatin accessibility data be integrated with other omics data?

Yes. Multi-omics integration with RNA-seq, ChIP-seq, CUT&Tag, methylation data, and Hi-C is a standard component of modern analysis pipelines, enabling construction of comprehensive regulatory models linking enhancers, transcription factors, and target genes.

What sample quality issues should be avoided?

Common pitfalls include low cell viability, excessive dead-cell contamination (which introduces artifacts), over-fixation, prolonged ischemia, and high mitochondrial DNA content. Proper sample handling, rapid processing, and pre-analytical quality assessment are essential for reliable results.